Note: Descriptions are shown in the official language in which they were submitted.
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
SURFACE TREATMENTS FOR ACCOMMODATING INTRAOCULAR
LENSES AND ASSOCIATED METHODS AND DEVICES
CROSS-REFERENCE TO RELATED APPLICATION(S)
[0001] The present application claims priority to U.S. Provisional
Application
Nos. 62/512,536, filed May 30, 2017, and titled SURFACE TREATMENTS FOR
HYDROPHILIC AIOL, and 62/560,527, filed September 19, 2017, and titled SURFACE
TREATMENTS FOR HYDROPHILIC AIOL, the contents of which are both incorporated
herein by reference in their entireties.
TECHNICAL FIELD
[0002] The present technology relates to medical devices and methods. In
particular,
embodiments of the present disclosure are directed to surface treatments for
accommodating
intraocular lenses (hereinafter "AIOLs" or "AIOL" for singular).
BACKGROUND
[0003] Cataracts can affect a large percentage of the worldwide adult
population with
clouding of the native crystalline lens and resulting loss of vision. Patients
with cataracts can be
treated by native lens removal and surgical implantation of a synthetic
intraocular lens ("IOL").
Worldwide, there are millions of IOL implantation procedures performed
annually. In the U.S.,
there are 3.5 million cataract procedures performed, while worldwide there are
over 20 million
annual procedures performed.
[0004] Although IOL implantation procedures can be effective at restoring
vision,
conventional IOLs have several drawbacks. For example, many prior IOLs are not
able to
change focus as a natural lens would (known as accommodation). Other drawbacks
of
conventional IOLs include refractive errors that occur after implantation and
require glasses for
correcting distance vision, or in other cases the IOLs can be effective in
providing good far vision
but patients need glasses for intermediate and near vision.
[0005] AIOLs have been proposed to provide accommodative optical power for
patients.
In particular, AIOLs for use in the replacement of the native lens, within the
lens capsule, allow
the brain to control the natural focusing of an external image on the retina
of the eye in the native
fashion. AIOLs typically comprise a central optical portion and a peripheral
non-optical portion.
-1-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
The optical portion is used to focus the image on the retina within the eye
and the non-optical
structural portion provides the support structure to hold the optical portion
in place and the
focusing or accommodating control mechanism which interfaces to the lens
capsule. Native
accommodation results from changing the focal length of the lens (natural or
artificial in this
case) within the lens capsule by tightening or relaxing the ciliary muscles,
which connect to the
perimeter of the capsule via the zonules. Hence the brain, via a control
feedback loop and action
on the ciliary muscles, controls the optical power of the AIOL to accommodate
the distance of
the object being focused on the retina.
[0006] However, prior AIOLs are generally still in development and have
different
drawbacks. For example, prior AIOLs can provide insufficient accommodation
after
implantation or produce suboptimal refractive correction of the eye. The
amount of
accommodation of the prior AIOLs can also decrease after implantation in at
least some
instances. The prior AIOLs can also be too large to be inserted through a
small incision of the
eye and may require the incision to be somewhat larger than would be ideal.
Also, at least some
of the prior AIOLs can be unstable when placed in the eye, which can lead to
incorrect
accommodation and other errors. Many prior AIOLs are also susceptible to
internal reflections
associated with non-optical portions of the AIOL structure scattering into the
optical field of
view¨referred to as dysphotopsia. For purposes of this disclosure, all such
internal reflections
will be termed "dysphotopsia."
[0007] Improved implantable intraocular lenses that accommodate with the
natural
mechanisms of controlling focusing of the eye that overcome at least some of
the above
deficiencies would be desirable. Ideally, such improved AIOLs would provide
increased
amounts of accommodation when implanted, provide refractive stability,
introduce few if any
perceptible visual artifacts, and allow the optical power of the eye to change
from far vision to
near vision in response to the distance of the object viewed by the patient.
SUMMARY
[0008] Embodiments of the present disclosure provide improved AIOLs and
methods for
making and using AIOLs. In many embodiments, the AIOLs include accommodating
structure
comprising a substantially hydrophilic outer structure and a substantially
hydrophobic fluid
interior. The hydrophilic structure is expected to provide a stable and very
compliant structure
capable of controlled deformation via minimal forces sustainable by the
focusing mechanisms
of the native lens.
-2-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
[0009] The hydrophobic fluid provides a high refractive index while
minimizing osmotic
effects. The high refractive index providing good optical power. The
substantially hydrophilic
structural material is typically made or fabricated from copolymers of
acrylics, copolymers of
hydrophilic acrylics and hydrophobic acrylics, or other optically transparent
polymeric material.
The hydrophilicity of the material will vary as a function of the relative
proportion of hydrophilic
and hydrophobic monomers which have been polymerized to create the materials.
[0010] In many embodiments, the hydrophilic outer structure is comprised of
components
that are machined from the hydrophilic materials in a relatively dry form,
assembled in the dry
form, the structure hydrated after assembly, the refractive oil introduced
after hydration.
[0011] The machining step may leave portions of the surface with different
degrees of
roughness and/or hydrophilicity.
[0012] The substantially hydrophobic fluid interior is comprised a
hydrophobic oil chosen
but not limited to any of silicone, copolymers of silicone and hydrocarbon
oils.
[0013] When AIOL is placed in the capsule bag (implanted), following a
conventional
cataract surgery, the AIOL comprising the substantially hydrophilic outer
structure and a
substantially hydrophobic fluid interior prevents the water from coalescing at
the boundary
surface defined as the interface of the hydrophilic material and the
hydrophobic fluid. In another
embodiment, the AIOL comprising the substantially hydrophilic outer structure
and a
substantially hydrophobic fluid interior, retards the water from coalescing at
the boundary
surface defined as the interface of the hydrophilic material and the
hydrophobic fluid. However,
in some instances water may coalesce at the boundary surface. Without being
bound by any
particular theory, it is believed the likelihood of water coalescence can
increase as a function of
surface roughness or surface irregularities of the hydrophilic structure at
the boundary of the
hydrophobic fluid and hydrophilic structure. Similarly, without being bound by
any particular
theory, it is believed the likelihood of water coalescence can increase with
changes in the
equilibrium moisture content of the hydrated hydrophilic structure with
changes in temperature.
Such temperature changes can occur when the AIOL is placed from its storage at
room
temperature to the temperature existing in the eye. Again, without being bound
by any particular
theory, it is believed the likelihood of water coalescence can increase with
changes in internal to
external pressure.
[0014] Over time, such coalesced water may be forced out of the inner
chamber into the
hydrophilic structure. In one embodiment, this process will be enhanced by a
positive pressure
-3-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
gradient from the interior to the outer environment. In another embodiment, as
the AIOL
equilibrates over time, the hydrophobic fluid pushes the water back from the
boundary surface
into the more compatible hydrophilic outer structure which is surrounded by
the hydrophilic
environment existing in the eye and thus acts as a sink for additional
moisture diffusing out.
[0015] In one possible scenario, neighboring coalesced water may form an
agglomerate
or water drops that may take longer to be driven out of the interior or the
boundary surface in a
reasonable amount of time. Such water drops can also negatively affect optical
quality of the
AIOL. Further, in some instances, water may form into droplets at the surface.
Additionally, in
some instances, these droplets may comprise a micelle. In one embodiment of
the present
technology, the possibility of water drops coalescing within the fluid
interior or at the interface
of the hydrophilic material and the hydrophobic fluid is reduced by providing
a surface treatment
to increase the hydrophobicity (i.e., decrease the surface energy) of the
boundary surfaces
thereby decreasing the "wettability" of these surfaces. In some embodiments,
the present
technology is expected to reduce the possibility of water drops coalescing
within the fluid
interior or at the interface of the hydrophilic material and the hydrophobic
fluid by providing a
surface treatment to increase the hydrophobicity of the boundary surfaces
thereby making it more
compatible to the hydrophobic fluid. In further embodiments, the present
technology is expected
to reduce the possibility of water drops coalescing within the fluid interior
or at the interface of
the hydrophilic material and the hydrophobic fluid by application or addition
of hydrophobic
surface treatment or hydrophobic coating that can adhere to hydrophilic
material to retard or
minimize or block the moisture diffusion to the interface between the of the
hydrophilic material
and the hydrophobic fluid.
[0016] In some embodiments, surface treatments in accordance with the
present
technology modify a boundary volume of the hydrophilic structural material at
and adjacent the
boundary surface to some depth into the structural material. In such
embodiments, the relative
proportion of hydrophobic to hydrophilic molecules and/or end or pendant
groups is increased
within this boundary volume. For purposes of this disclosure, the terms
"molecules" and "end
or pendant groups" are used interchangeably.
[0017] In some such embodiments the proportion of hydrophobic molecules
within the
volume after treatment varies as a function of depth. In such embodiments the
proportion of
hydrophobic molecules is greatest at the boundary surface and decreases deeper
into the
structural material. Although such a distribution or gradient in concentration
is not strictly a
-4-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
coating, for purposes of this disclosure, "coating" will be used to describe
both a material lying
on top of another, and the formation of a gradient in molecular distribution
in material adjacent
a coated surface, or a combination of both.
[0018] When choosing a coating material, it will be appreciated that
depending up on the
proportion of hydrophilic material to hydrophobic material, swelling of the
coating can vary
from swelling of the base material upon hydration of both materials. Such
differential swelling
may cause internal stresses, strains, and or delamination which may be
detrimental to the
function of the AIOL.
[0019] In many of the embodiments described herein a treatment comprises
applying a
coating material, which comprises a solution of monomers (and/or in some
instances oligomers),
crosslinkers, and a catalyst to initiate crosslinking of the monomers.
Although the treatments
described herein typically increase the hydrophobicity of the surfaces or
materials, such
treatments and coating materials may be modified such that the hydrophilicity
may be increased.
[0020] In other aspects of the present technology, the same or similar
surface treatments
are applied to the interior surfaces of the AIOL device to minimize to reduce
the surface
roughness of the machined surfaces. In another aspect of the present
technology, the same or
similar surface treatments are applied to the exterior surfaces of the AIOL
device to minimize
the migration of proteins into the AIOL structure and or the attachment of
cells to the outer
surface of the AIOL structure.
[0021] In another application of the materials and methods described
herein, coatings may
be used to modify the reflective characteristics at or near the surfaces of
the structures comprising
the AIOL. Such materials and methods can provide for reductions and or
elimination of light
delivered to the retina which has been captured by and or transmitted through
non-optical
portions of the AIOL system and or result from multiple internal reflections.
Such light often
results from internal reflections associated with non-optical portions of the
AIOL structure. Such
treatments will reduce and or eliminate the occurrence of dysphotopsia
resulting from such
internal reflections associated with AIOL implantation.
BRIEF DESCRIPTION OF THE DRAWINGS
[0022] Features of the present technology are set forth with particularity
in the appended
claims. A better understanding of the features and advantages of the present
technology will be
obtained by reference to the following detailed description that sets forth
illustrative
-5-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
embodiments, in which the principles of the invention are utilized, and the
accompanying
drawings of which:
[0023] Figure 1A shows an isometric view of a fluid filled accommodating
lens system
comprising a bellows structure and a surface treatment configured in
accordance with an
embodiment of the present technology.
[0024] Figure 1B shows a cross-sectional view of the fluid filled
accommodating lens
system of Figure 1A.
[0025] Figure 1C shows a cross-sectional view of the fluid filled
accommodating lens
system of Figure 1A taken along line A-A.
[0026] Figure 2A shows a cross-sectional view of an alternate accommodating
lens system
configured in accordance with an embodiment of the present technology.
[0027] Figure 2B and Figure 2C illustrate top views of a first component
and a second
component, respectively, of an accommodating lens system configured in
accordance with an
embodiment of the present technology.
[0028] Figure 3A illustrates a laser profilometery image of a portion of a
machined surface
of an accommodating lens system configured in accordance with an embodiment of
the present
technology.
[0029] Figure 3B is a display diagram illustrating a profile of a portion
of a machined
surface of an accommodating lens system.
[0030] Figures 4A and 4B illustrate a section of a hydrophilic
accommodating lens
structure including a base layer and a light attenuating layer or coating
layer in accordance with
an embodiment of the present technology.
[0031] Figure 5A shows a cross-sectional view of a surface treated portion
of an
accommodating lens structure configured in accordance with yet another
embodiment of the
present disclosure.
[0032] Figure 5B graphically represents a relative surface energy
associated with material
at given depths through the cross section of Figure 5A.
-6-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
DETAILED DESCRIPTION
[0033] The present disclosure is directed to surface treatments for AIOLs
and associated
systems, methods, and devices. AIOLs, as described herein, are typically
fabricated from dry
hydrophilic components, which are hydrated prior to incorporating the
substantially hydrophobic
fluid interior into the assembly and the resulting assembly is kept in a
hydrated state after
manufacture. The surface treatments described herein will typically be applied
to the dry pre-
hydrated components or assemblies. In other embodiments, however, the surface
treatments
described herein may be applied to the components or assemblies in a fully
hydrated state to take
advantage of higher surface area (accessible in the hydrated state). In some
instances, surfaces
that are not to be treated can be masked. In other instances, the treatment
may be applied without
a mask.
[0034] AIOLs, as described herein, typically comprise a central optical
structure
comprised of at least one deformable optical component (e.g., an optical
element) spaced apart
along an optical axis, such as by a support structure concentric with the
optical axis of the lenses.
Several embodiments include a first optical component and a second optical
component, and at
least one of the first and second optical components can be deformable while
the other of the
first and second optical components can be deformable or rigid. The volume
bounded by the
first and second optical components, and optionally the lens support
structure, may define a fluid
chamber or fluid reservoir that can be filled with an ionic solution, such as
saline, or non-ionic
solutions such as dextran or silicone oil. In some embodiments of the AIOLs
described herein,
the AIOL components are machined from a dry pre-hydrated hydrophilic material.
The
machined components are then assembled such that the assembled AIOL comprises
an outer
surface, and an inner volume bounded by an inner surface. The inner volume is
then filled by a
hydrophobic optical fluid after the assembled device is hydrated. In some
embodiments, the
surface treatment is expected to decrease the roughness of the machined
surfaces of the boundary
surfaces and thereby reduce the mass of water coalescing at the boundary
surface.
[0035] In other embodiments described herein, suitable coatings may be used
to minimize
dysphotopsia. Such coatings may comprise, for example, agents that minimize
the amount of
light transmitted through the coating. Transmission may be modified by
increasing the scattering
of light at the surface of the coating or within the coating, reflecting and
or absorbing the light
at the surface of or within the coating, or some combination. Such light
interactions can be
effected by the incorporation of particles within the coating material. A non-
exhaustive list of a
-7-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
few such additive materials are opaque particles such as TiO2, gas bubbles,
and water-soluble
(or other solvent soluble) particles such as sugars or salts.
[0036] The hydrophilic acrylics described herein may include copolymers of
both
hydrophilic and hydrophobic components. The following is a partial list of
some such
component materials: 2-Hydroxyethyl methacrylate (HEMA), 2-Ethoxyethyl
methacrylate
(EOEMA), Ethylene glycol dimethylacrylate (EGDMA), polymethyl methacrylate
(PMMA),
Butyl acrylate, Hexyl acrylate and Hexafluoroisopropyl acrylate.
[0037] One suitable hydrophilic copolymer acrylic from which AIOLs
described herein
may be fabricated is a copolymer of HEMA and EOEMA. Such a material is BENZ
IOL 25
UVX which may be purchased from Benz Research & Development, 6447 Parkland
Dr.,
Sarasota, FL 34243 United States.
[0038] In some embodiments, surface treatments are aimed at minimizing,
retarding or
preventing water coalescence, and will be applied to the boundary surfaces
described as the
interface of the hydrophilic material and the hydrophobic fluid.
[0039] Treatments applied to the exterior surfaces of the AIOL to minimize
migration of
organic molecules or proteins typically comprise a smaller increase in
hydrophobicity or a
smaller reduction in hydrophilicity or a smaller reduction in surface energy
than those applied
to the inner boundary surfaces of the chamber surrounding the substantially
hydrophobic fluid.
[0040] The nature and amount of surface treatment applied in accordance
with the present
technology can be controlled. In one embodiment, for example, the surface
treatments will
slightly decrease the surface energy and slightly increase the surface
hydrophobicity of the
hydrophilic material. In another embodiment, the surface treatments will
decrease the surface
energy and increase the surface hydrophobicity of the hydrophilic material. In
still another
embodiment, the surface treatments will substantially decrease the surface
energy and
substantially increase the surface hydrophobicity of the hydrophilic material.
[0041] In some embodiments, hydrophobicity is achieved by treating the
boundary
surfaces, or portions of the boundary surfaces, with surface treatment agents
which comprise a
portion to affix to the hydrophilic material while presenting another
hydrophobic portion to the
interior of the chamber surrounding the substantially hydrophobic fluid. The
hydrophobic
portions applied to the boundary surfaces may have different chemical
compositions and
-8-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
different degree of hydrophobicity than those applied to the interior of the
chamber surrounding
the substantially hydrophobic fluid.
[0042] In some such treatments, a molecule with a hydrophobic end group can
be
chemically affixed to the surface of interest such that the hydrophobic end
group is presented to
the exterior. Chemically affixed may include either covalently bonds, hydrogen
bonds, or
chemical crosslinking. In another such surface treatments, a hydrophobic
molecule can be
covalently bonded, chemically crosslinked, or adhered by hydrogen bonding to
the surface of
interest. For chemical cross-linking, biocompatible cross linkers such as
amines, trifunctional
or multifunctional hydroxyl compound, glycerin, acrylics and Ethylene glycol
dimethacrylate
[EGDMA] can be used.
[0043] The application area of the surface treatment can be continuous,
semi-continuous
or in separate patches. In an alternative treatment for use with copolymers
comprised of
hydrophilic and hydrophobic constituents, a surface treatment may be applied
which
preferentially etches the hydrophilic portions while leaving intact the
hydrophobic portions.
[0044] In yet another alternative the surface treatment comprises applying
a layer of
copolymer to the surface of interest which has a much lower hydrophilicity or
a much lower
saturation water content than the AIOL assembly or outer structure material.
Alternatively, or
in combination, the surface treatment substantially covers the channels or
passages in the outer
structure material in order to prevent or resist the diffusion of moisture
through the surface layer
in the hydrated use state of the outer structure material. In some such
embodiments, the
copolymer may contain the same constituents as the hydrophilic base material
being coated but
in different proportions of hydrophilic acrylics and hydrophobic acrylics. In
one embodiment,
the surface treatment comprises at least 50% of the hydrophobic acrylics by
weight. In another
embodiment, the surface treatment comprises at least 70% of the hydrophobic
acrylics by weight.
In another embodiment, the surface treatment comprises at least 90% of the
hydrophobic acrylics
by weight. In some embodiments, the surface treatment comprises a thin coating
of material of
the same surface energy as the structure applied in such a fashion as to
reduce the roughness of
the surfaces resultant from the manufacturing processes.
[0045] The surface treatments can be delivered by various methods such as
brush coating,
spray coating, dip coating, vapor deposition, plasma deposition or their
combinations thereof
In embodiments in which the coating material is delivered in a solvent, useful
biocompatible
solvents include but not limited to NMP, DMSO, TCE, ethyl acetate, THF, DMF
and DMAC.
-9-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
[0046] In one embodiment, the surface of interest may undergo one surface
treatment. In
another embodiment, the surface of interest may undergo two surface
treatments. In yet another
embodiment, the surface of interest may undergo more than two surface
treatments.
[0047] In some instances, the surfaces to be treated will be prepared or
pretreated by
surface modifications or surface activation such as treatments by; UV
exposure, plasma, corona
discharge, alcohol etching solvent cleaning and acidic etching.
[0048] In some instances, the surfaces to be treated will be prepared by
surface
modifications or surface activation such as treatments which replace OH groups
with other
groups which render the surface less hydrophilic.
[0049] Materials comprised in the surface treatments may be selected from,
but are not
limited to, any of the following: Silicone, Polyurethane, and Acrylic.
[0050] In one embodiment, the silicone for the surface treatment comprises
a linear
silicone polymer. In another embodiment, the silicone for the surface
treatment comprises a
cross-linked silicone polymer.
[0051] In one embodiment, the polyurethane for the surface treatment
comprises an
aromatic hard segment. In another embodiment, the polyurethane for the surface
treatment
comprises an aliphatic hard segment. In still other embodiments, the
polyurethane for the surface
treatment may comprise hydrophobic polyurethanes such as polycarbonate
polyurethane,
poly(carbonate-co-siloxane) polyurethane, polysiloxane polyurethane, polyether
polyurethane,
poly(ether-co-carbonate) polyurethane, or poly(ether-co-siloxane), a linear
urethane polymer,
and/or a cross-linked urethane polymer.
[0052] In one embodiment, the acrylic comprises a hydrophobic acrylic. In
another
embodiment, the acrylic comprises a copolymer of hydrophilic acrylics and
hydrophobic
acrylics. Exemplary hydrophilic acrylics include but are not limited to 2-
Hydroxyethyl
methacrylate (HEMA). Exemplary hydrophobic acrylics include but are not
limited to 2-
Ethoxyethyl methacrylate (EOEMA), polymethyl methacrylate (PMMA), Butyl
acrylate, Hexyl
acrylate and Hexafluoroisopropyl acrylate. In one embodiment, the acrylic
comprises a
crosslinker. In one embodiment, the acrylic comprises a cross-linked acrylic
polymer.
[0053] The average thickness of surface treatment is less than 20
micrometers, preferably
less than 10 micrometers and more preferably less than 2 micrometers. The
surface treatment is
substantially chemical compatible with the hydrophilic outer structure leading
to better adhesion
-10-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
with the hydrophilic outer structure. The surface treatment will not degrade
or disintegrate in
aqueous environment and is hydrolytically stable. The surface treatment is
ductile and optically
clear so it will not interfere with functioning of the AIOL. The surface
treatment is
biocompatible.
[0054] Several possible Acrylic-based recipes are presented in Table A and
Table B
below. Several more possible treatment material recipes and procedures are
listed in the
Examples below.
A selection of possible curing cycles
(examples) for the acrylic materials listed
in Table A are 4-18 hours at 60C, 4-24
hours at 50C, 10 hours at 30C and 5 hours
100C. Formula
1 Formula 2 Formula 3 Formula 4
(all by weight)
EOEMA family
2-Ethoxyethyl methacrylate
[EOEMA] 30% 60% 99.63% 97.02%
2-Hydroxyethyl methacrylate
[HEMA] 69.63% 39.63% 0% 0%
2,2-azobis (2,4-
dimethylvaleronitrile) 0.07% 0.07% 0.07% 0.068%
Ethylene glycol dimethacrylate
[EGDMA] 0.30% 0.30% 0.30% 2.91%
FLUORO family
1,1,1,3,3,3-Hexafluoroisopropyl
acrylate 63.19% 62.79% 58.49%
Butyl acrylate 36.44% 32.02% 0.00%
Hexyl acrylate 0.00% 0.00% 41.14%
4-Hydroxybutylacrylate 0.00% 4.81% 0.00%
Ethylene glycol dimethacrylate
[EGDMA] 0.30% 0.30% 0.30%
-11-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
2,2-azobis (2,4-
dimethylvaleronitrile) 0.07% 0.07% 0.07%
EGDMA is a crosslinker
Azobis is a thermal and UV initiator
Table A
Compound (all by weight) 1% HEMA
5% HEMA 25% HEMA 50% HEMA
2-HydroxyethylMethacrylate
1.00% 5.00% 25.00% 50.00%
(HEMA)
2-EthoxyethylMethacrylate
98.50% 95.00% 75.00% 50.00%
(EOEMA)
Ethylene glycol dimethacrylate
0.30% 0.30% 0.30% 0.30%
(EGDMA)
2,2'-Azobis(2,4-dimethylvaleronitrile) 0.07% 0.07% 0.07%
0.07%
Table B
[0055]
Coatings described herein may be applied by any suitable means including, for
example, painting, spraying, vapor deposition processes, and/or application
via a mist chamber.
One useful application method comprises subjecting the surface and adjacent
volume of
structural material to a volume of the unpolymerized formula or partially
polymerized
(comprised of oligomers) formula. The time between the application of the
treatment and the
initiation (or re-initiation) of polymerization, treatment time, may be varied
for any of the
treatment methods. The treatment time will affect the depth of penetration of
the monomers and
multimers comprising the coating material prior to polymerization. The volume
of coating
material will be greater closer to the application surface and decrease as the
distance from the
coating surface increases.
[0056]
Figures 1A-1C illustrate various views of an AIOL 100 including a surface
treatment configured in accordance with an embodiment of the present
technology. Referring
first to Figures 1A and 1B, for example, the AIOL 100 comprises three primary
structures
including (a) a fixed lens assembly 150, (b) a first component 110, and (c) a
second component
120. The first component 110 is mated with and bonded to the second component
120. The
fixed lens assembly 150 is held in place relative to the first and second
components 110 and 120
via a mechanical interface and is not bonded in place.
-12-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
[0057] Figure 1C is a cross-sectional view of AIOL 100 taken along line A-A
of
Figure 1B. As best seen in Figure 1C, the first and second components 110 and
120 are bonded
together at seams or bond joints 104, 105, and 106 to couple the first and
second components
110 and 120 to one another. When bonded, an outer or peripheral portion 113 of
the first
component 110 and an outer or peripheral portion 123 of the second component
120 define an
outer surface 103 of the AIOL 100.
[0058] The first component 110 includes a first inner surface 111 having
one or more inner
surface regions defining various portions of the first component 110. In the
illustrated
embodiment, for example, the first component 110 includes a first inner
surface region 111a and
a second inner surface region 111b. The second component 120 also comprises a
second inner
surface 121 having one or more inner surface regions defining various portions
of the second
component. For example, the second component 120 includes a third inner
surface region 121a
and a fourth inner surface regions 12 lb. In the embodiment shown in Figure
1C, the first inner
surface region 111a (of the first component 110) and the third inner surface
region 121a (of the
second component 120) define, at least in part, a first bellows region 140a.
Similarly, the second
inner surface region 111b (of the first component 110) and the fourth inner
surface region 121b
(of the second component 120) define, at least in part, a second bellows
region 140b
(collectively, bellows region 140).
[0059] The AIOL 100 has a fluid accommodating lens 112 defined by a fluid
chamber or
reservoir 130 bounded between a first optical component 132 and a second
optical component
134. The first and second optical components 132 and 134 may be planar members
(e.g., optical
membranes) of the first and second components 110 and 120, respectively. The
first and second
optical components 132 and 134, for example, can be integrally formed as
optical membranes
with the other portions of the first and second components 110 and 120. In
alternate
embodiments, either or both of the membranes of the first and second optical
components 132
and 134 may be a lens (i.e., have an optical power).
[0060] The fluid chamber 130 is in fluid communication with the bellows
region 140 to
transfer fluid (e.g., the hydrophobic fluid) between the fluid chamber 130 and
the bellows region
140 in response to shape changes of the lens capsule to provide optical power
changes to the
accommodating intraocular lens. In some embodiments, for example, the fluid
chamber 130 and
the bellows region 140 may be filled with a substantially hydrophobic fluid
that is transferred
therebetween.
-13-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
[0061] Referring to Figures 1A and 1C together, the fixed lens assembly 150
includes an
optical portion 151 and passages 152. The optical portion 151 has a fixed
power that may
comprise an asymmetrically powered lens or other suitable lens, and the
passages 152 are holes,
slots, orifices, etc., that pass through and extend through a portion of the
fixed lens assembly
150, but not the optical portion 151. The fixed lens assembly 150 further
includes an inner
surface 154 facing and adjacent to an engagement surface of the first
component 110 and/or
second component 120 to which the fixed lens assembly 150 is coupled.
[0062] As noted previously, the AIOL 100 may include a surface treatment on
various
portions of one or more components of the AIOL 100. In some embodiments, for
example,
portions of inner surfaces 111 and 121 surrounding the bellows region 140 may
be treated to
reduce the surface energy or increase the surface hydrophobicity. In some
embodiments, some
or all of the mating surfaces are left untreated. In alternate embodiments,
all of inner surfaces
(including inner surfaces 111 and 121) are treated to reduce their surface
energy or increase the
surface hydrophobicity.
[0063] In some embodiments, only selected portions of inner surfaces 111
and 121 are
treated to reduce, prevent or resist the diffusion of moisture through the
surface layer. In
alternate embodiments, all or substantially all of inner surfaces 111 and 121
are treated to resist
the diffusion of moisture through the surface layer in the hydrated use state
of the outer structure
material.
[0064] In some embodiments, only the portions of outer surface 113
surrounding the fluid
accommodating region 112 may be treated to reduce the surface energy and/or
reduce prevent
or resist the diffusion of moisture through the surface layer. In alternate
embodiments, all of
outer surfaces 113 and 123 can be treated to reduce their surface energy,
reduce the pore size of
the surface layer, and/or increase the surface hydrophobicity.
[0065] In some embodiments, a surface treatment that resists the diffusion
of moisture
through the surface comprises substantially covering the channels or passages
in the outer
structure material of the AIOL 100 to prevent or resists the diffusion of
moisture through the
surface.
[0066] Suitable surface treatments for use with the AIOL 100 of Figures 1A-
1C and other
AIOLs configured in accordance with the present technology utilize a variation
of Formula 4 of
the EOEMA family listed in Table A provided above. In such embodiments, the
inner machined
surfaces of the first and second components 110 and 120 of AIOL 100 (Figures
1A-1C) may be
-14-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
treated in a dry state prior to assembly by spraying the coating material. In
some embodiments,
some combination of the surfaces comprising bond joints 104, 105, 106 can be
masked during
the coating process.
[0067] In an alternate procedure, the first and second components 110 and
120 can be
filled with a coating material and the coating material is allowed to diffuse
into the structural
material for a period of time between 1 minute 1 day, more preferably between
5 minutes and
20 minutes prior to the initiation of polymerization. In certain embodiments,
selected surfaces
of the first component 110 and second component 120 (e.g., the bond joints
104, 105, 106 and/or
other selected surfaces) may be masked.
[0068] Figures 2A, 2B, and 2C illustrate an AIOL 200 configured in
accordance with
another embodiment of the present technology. The AIOL 200 is similar to
embodiments of the
AIOL 100 described above with reference to Figures 1A-1C. For example, the
AIOL 200
comprises three primary structures including (a) a fixed lens assembly 250,
(b) a first component
210, and (c) a second component 220. The first and second components 210 and
220 are bonded
together at seams or bond joints 204, 205, and 206 to couple the first and
second components
210 and 220 to one another. After bonding, an outer or peripheral portion 213
of the first
component 210 and an outer or peripheral portion 223 of the second component
220 define an
outer surface 203 of the AIOL 200. The AIOL 200 further includes an inner
surface 211.
[0069] As best seen in Figure 2A, the fixed lens assembly 250 can be
engaged to and
aligned with a fluid accommodating lens 260 of the AIOL 200 by engaging a
continuous
thickened region 253 of the first component 210 with an engagement feature 255
of the fixed
lens assembly 250.
[0070] Figures 2B and 2C are top views of the first component 210 and
second component
220, respectively, before being joined together. As best seen in Figures 2B
and 2C, certain
portions of the AIOL 200 may be masked before/during a surface treatment or
coating process.
Such masked regions 207 are typically regions where the first component 210
and the second
component 220 are bonded together¨including, for example, seams/bond joints
204 (Figure
2A), 205 (Figure 2C), and 206. Many suitable bonding agents are designed for
hydrophilic base
materials. Accordingly, masking the selected regions before the surface
treatment or coating
process will ensure that such regions are not subjected to the surface
treatment, and thereby allow
the masked regions to provide enhanced bonding between the first and second
components 210
and 220. It will be appreciated that in other embodiments additional regions
or different regions
-15-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
of the first component 210 and/or second component 220 may be masked before
surface
treatment. Further, in some embodiments no masking may be used during surface
treatment or
coating.
[0071] Figure 3A illustrates a laser profilometery image of a portion of a
machined surface
309 of the BENZ material. On the left side of the drawing is a coated surface
301 and on the
right side of the drawing is an uncoated surface 302. Element 308 illustrates
an arbitrary cross
section of the surface. Figure 3B is a graphic representation of the profile
308 as a function of
distance and height (d, h) and its first derivative (d, dh/dd). As can be seen
both in the surface
illustration of Figure 3A and the cross-section illustration of Figure 3B, a
surface treatment or
coating reduces surface roughness. In particular, the first derivative of the
profile on the coated
portion can be seen to fall within a relatively small range while the first
derivative on the profile
on the uncoated region varies dramatically.
[0072] Figure 4A illustrates a section of a hydrophilic AIOL structure 435a
comprising a
base layer 436 and a light attenuating layer or coating layer 431. The light
attenuating layer 431
is rendered less transparent by means of any of the techniques discussed
herein. Figure 4B
illustrates another arrangement of a section of a hydrophilic AIOL structure
435b comprising
the base layer 436 with the light attenuating layer 431 sandwiched between the
base layer 436
and a coating layer 433. The coating layer 433 may be a clear layer or can
include a dye or some
other material. The treatments shown in Figures 4A and 4B, when applied to
regions of the
AIOL outside the optical field of view, can be used to minimize dysphotopsia.
When applied in
such a fashion, the amount of stray light (either entering or reflected from
the coated surfaces)
entering the optical field of view is expected to be reduced or minimized.
[0073] Figure 5A illustrates an arbitrary cross section of a surface
treated portion of an
AIOL as described herein. The disclosed arrangement comprises a thin layer of
coating material
overlaying the body material. Figure 5B graphically represents the relative
surface energy
associated with material at given depths through the cross section of Figure
5A. The surface
energy is described in terms proportion of hydrophilic end groups vs
hydrophobic end groups.
As best seen in Figure 5B, the coating is more hydrophobic than the body
material. As a result
of the surface treatment process, there is a transition region within the body
material in which
addition hydrophobic end groups are incorporated indicated by the diagonal
portion of the curve
in Figure 5B.
-16-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
Additional Examples:
1. Coating composition
a. Benz type formulations
b. Fluro formulations
c. Silanol coating
2. Coating methods
a. Soak: almost all monomers
b. Vapor deposition: Parylene
c. Paint: thick monomers/viscous polymers
3. Coating initiation methods
a. Thermal: Azobis and Esperox
b. Photochemical: Azobis
4. High viscosity solutions
5. Coating expected outcomes
a. Coating thickness
b. Hydrophobicity of coatings
c. Change surface texture
6. Measurements methods
a. FTIR: ATR
b. EDX: Auger
c. Contact angles
7. Methods
Example 1: Azobis Thermal Initiator
[0074] A mixture containing xx gm of 2-HEMA, yy gm of EOEMA, zz gm of 2,2-
azobis
(2,4 dimethyl valeronitrile) and 0.3% by weight (of total mixture weight) of
ethylene glycol
dimethacrylate (EGDMA) were prepared in a clean vial. The mixture was
thoroughly mixed
-17-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
using a magnetic stirrer making sure that there were no undissolved solid
particles and there
were no schlerian lines visible. The mixture was later filtered in a clean
room through a 0.2
microns filter to remove any possible floating particles etc.
[0075] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and other areas were protected from contact with the coating
agents. The parts to
be coated were dipped in the mixture from Table 1 for about 1-60 seconds and
removed making
sure that a film of the coating mixture was deposited. The lens was placed in
an oven at 60 C
to cure for about 18 hours. Characterize by FTIR-ATR, contact angle(s) values
and EDX.
[0076] The exact formulations with values of xx, yy, zz are shown in Table
1.
Example 2: UV Initiator
[0077] A mixture containing xx gm of 2-HEMA, yy gm of EOEMA, zz gm of 2,2-
azobis
(2,4 dimethyl valeronitrile) and 0.3% by weight (of total mixture weight) of
ethylene glycol
dimethacrylate (EGDMA) were prepared in a clean vial. The mixture was
thoroughly mixed
using a magnetic stirrer making sure that there were no undissolved solid
particles and there
were no schlerian lines visible. The mixture was later filtered in a clean
room through a 0.2
microns filter to remove any possible floating particles, etc.
[0078] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with coating
agents. The parts to
be coated were dipped in the mixture from Table 1 for about 1-60 seconds and
removed making
sure that a film of the coating mixture was deposited. The lens was treated
with a UV medium
pressure mercury lamp with light emitting at a wavelength of >350 nm for about
2-6 minutes.
The lamp was turned off and the parts were removed. Characterize by FTIR-ATR,
contact angles
values and EDX.
[0079] The exact formulations with values of xx, yy, zz are shown in Table
1.
2,2-azobis (2,4-
HEMA EGDMA EOEMA dimethylvaler
(gm) (gm) (gm) onitrile)
(gm)
1 9.76 0.22 21.53 0.05
2 20.38 0.11 10.33 0.05
3 9.11 0.84 20.09 0.05
-18-
CA 03064855 2019-11-25
WO 2018/222579 PCT/US2018/034858
4 19.81 0.42 10.05 0.05
16.71 0.36 13.78 0.05
Table 1
Example 3: Esperox Thermal Initiator
[0080] A mixture containing xx gm of 2-HEMA, yy gm of EOEMA, zz gm of
Esperox 33
(tert-Butyl peroxyneodecanoate, from Akzo Nobel Industries) and 0.3% by weight
(of total
mixture weight) of ethylene glycol dimethacrylate (EGDMA) were prepared in a
clean vial. The
mixture was thoroughly mixed using a magnetic stirrer making sure that there
were no
undissolved solid particles and there were no schlerian lines visible. The
mixture was later
filtered in a clean room through 0.2 microns filter to remove any possible
floating particles etc.
[0081] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with the coating
agents. The parts
to be coated were dipped in the above mixture from Table 2 for about 1-60
seconds and removed
making sure that a film of the coating mixture was deposited. The lens was
placed in an oven at
40 C to cure for about 18 hours. Characterize by FTIR-ATR, contact angle(s)
values and EDX.
[0082] The exact formulations with values of xx, yy, zz are shown in Table
2 below.
Esperox 33
HEMA EGDMA EOEMA
(tert-Butyl
(gm) (gm) (gm)
peroxyneodecanoate)
1 9.76 0.22 21.53 0.05
2 20.38 0.11 10.33 0.05
3 9.11 0.84 20.09 0.05
4 19.81 0.42 10.05 0.05
5 16.71 0.36 13.78 0.05
Table 2
Example 4: UV Initiator
[0083] A mixture containing xx gm of 1,1,1,3,3,3-Hexafluoroisopropyl
acrylate (gm), yy
gm of Butyl acrylate (gm), and/ or xy gm of 4-Hydroxybutyl acrylate (gm) zz gm
of 2,2-azobis
(2,4 dimethyl valeronitrile) and 0.3% by weight (of total mixture weight) of
ethylene glycol
dimethacrylate (EGDMA) was prepared in a clean vial. The mixture was
thoroughly mixed
-19-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
using a magnetic stirrer making sure that there were no undissolved solid
particles and there
were no schlerian lines visible. The mixture was later filtered in a clean
room through a 0.2
microns filter to remove any possible floating particles etc.
[0084] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with coating
agents. The parts to
be coated were dipped in the above mixture from Table 3 for about 1-60 seconds
and removed
making sure that a film of the coating mixture was deposited. The lens was
treated with a UV
medium pressure mercury lamp with light emitting at a wavelength of >350 nm
for about 2-6
minutes. The lamp was turned off and the parts were removed. Characterize by
FTIR-ATR,
contact angle(s) values and EDX.
[0085] The exact formulations with values of xx, yy, xy, zz are shown in
Table 3.
1,1,1,3,3,3- Ethylene glycol
Butyl 2,2-azobis (2,4-
Hexafluorois 4-Hydroxybutyl dimethacrylate
acrylate dimethylvalero
opropyl acrylate (gm) (EGDMA)
(gm) nitrile) (gm)
acrylate (gm) (gm)
1 3.0000 1.7300 0.0032 0.0000 0.0144
2 3.0000 1.5300 0.0035 0.2300 0.0145
3 3.0000 2.1100 0.0034 0 0.0155
Table 3
Example 5: Azobis Thermal Initiator
[0086] A mixture containing xx gm of 1,1,1,3,3,3-Hexafluoroisopropyl
acrylate (gm), yy
gm of Butyl acrylate (gm), and/ or xy gm of 4-hydroxybutyl acrylate (gm) zz gm
of 2,2-azobis
(2,4 dimethyl valeronitrile) and 0.3% by weight (of total mixture weight) of
ethylene glycol
dimethacrylate (EGDMA) was prepared in a clean vial. The mixture was
thoroughly mixed
using a magnetic stirrer making sure that there were no undissolved solid
particles and there
were no schlerian lines visible. The mixture was later filtered in a clean
room through 0.2
microns filter to remove any possible floating particles etc.
[0087] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with the coating
agents. The parts
to be coated were dipped in the above mixture from Table 3 for about 1-60
seconds and removed
-20-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
making sure that a film of the coating mixture was deposited. The lens was
placed in an oven at
60 C to cure for about 18 hours. Characterize by FTIR-ATR, contact angle(s)
values and EDX.
[0088] The exact formulations with values of xx, yy, xy, zz are shown in
Table 3.
Example 6: Esperox Thermal Initiator
[0089] A mixture containing xx gm of 1,1,1,3,3,3-Hexafluoroisopropyl
acrylate (gm), yy
gm of Butyl acrylate (gm), and/ or xy gm of 4-hydroxybutyl acrylate (gm l zz
gm of Esperox 33
[0090] (tert-Butyl peroxyneodecanoate) and 0.3% by weight (of total mixture
weight) of
ethylene glycol dimethacrylate (EGDMA) was prepared in a clean vial. The
mixture was
thoroughly mixed using a magnetic stirrer making sure that there were no
undissolved solid
particles and there were no schlerian lines visible. The mixture was later
filtered in a clean room
through 0.2 microns filter to remove any possible floating particles etc.
[0091] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with the coating
agents. The parts
to be coated were dipped in the above mixture from Table 3 for about 1-60
seconds and removed
making sure that a film of the coating mixture was deposited. The lens was
placed in an oven at
40 C to cure for about 18 hours. Characterize by FTIR-ATR, contact angle(s)
values and EDX.
[0092] The exact formulations with values of xx, yy, xy, zz are shown in
Table 4.
Esperox 33
1,1,1,3,3,3-
Butyl (tert-Butyl Ethylene glycol
Hexafluoroiso 4-Hyd roxyb utyl
acrylate peroxyneodecan dimethacrylate
propyl acrylate (gm)
(gm) oate (EGDMA) (gm)
acrylate (gm)
(gm)
1 3.0000 1.7300 0.0032 0.0000 0.0144
2 3.0000 1.5300 0.0035 0.2300 0.0145
3 3.0000 2.1100 0.0034 0 0.0155
Table 4
Example 7: Siloxane Coating
[0093] A 95% ethanol in water solution was mixed with about 2 ml acetic
acid and the pH
was measured to be 4.5-5.5. The temperature was maintained to ambient (20 C).
The pH was
adjusted if necessary to remain in the range of 4.5-5.5. A 2.0 ml solution of
octyltriethoxysilane
-21-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
was measured in a hood and was added to the liquid slowly. The total time from
the start of
mixing the octyltriethoxysilane was 5 minutes.
[0094] In a separate process, the lens parts to be coated were prepared.
The side to be
coated was exposed and all other areas were protected from contact with
coating agents. The
parts to be coated were brought in contact with the above mixture for about 60-
90 seconds. The
parts were removed after 90 seconds and allowed to cure for about 24 hours at
room temperature
or 6-8 hours at 60 C in an oven.
[0095] Characterize by FTIR-ATR, contact angle(s) values and EDX.
Example 8: Preparation of Thicker Coating Using UV Polymerization
[0096] A mixture containing xx gm of 2-HEMA, yy gm of EOEMA, zz gm of 2,2-
azobis
(2,4 dimethyl valeronitrile) and 0.3% by weight (of total mixture weight) of
ethylene glycol
dimethacrylate (EGDMA) was prepared in a clean vial per Table 1. The total
volume of the
mixture was adjusted to about 30 ml. The mixture was placed in a 40 ml glass
vial. A magnetic
stirrer was placed inside the mixture and was heated to 80-90 C for about 8-
10 minutes. The
monomer solution was monitored closely. When the vortex created by the stir-
bar completely
disappeared (e.g. the surface of the liquid was completely flat), the monomer
was removed
quickly from the stir plate and was placed in the ice water. The monomer was
agitated
horizontally until it cooled completely.
[0097] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with the coating
agents. The parts
to be coated were dipped in the above mixture or the viscous solution was
painted over it. The
lens was treated with a UV medium pressure mercury lamp with light emitting at
a wavelength
of >350 nm for about 2-6 minutes. The lamp was turned off and the parts were
removed.
[0098] Characterize by FTIR-ATR, contact angle(s) values and EDX.
[0099] The exact formulations with values of xx, yy, xy, zz are shown in
Table 1.
Example 9: Preparation of Thicker Coating and Thermal Polymerization
[0100] A mixture containing xx gm of 2-HEMA, yy gm of EOEMA, zz gm of 2,2-
azobis
(2,4 dimethyl valeronitrile) and 0.3% by weight (of total mixture weight) of
ethylene glycol
dimethacrylate (EGDMA) was prepared in a clean vial per Table 1. The total
volume of the
mixture was adjusted to about 30 ml. The mixture was placed in a 40 ml glass
vial. A magnetic
-22-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
stirrer was placed inside the mixture and was heated to 80-90 C for about 8-
10 minutes. The
monomer solution was monitored closely. When the vortex created by the stir-
bar completely
disappeared (e.g. the surface of the liquid was completely flat), the monomer
was removed
quickly from the stir plate and was placed in the ice water. The monomer was
agitated
horizontally until it cooled completely.
[0101] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with coating
agents. The parts to
be coated were dipped in the above mixture or the viscous solution was painted
over it. The
coated parts were placed at 60 C in an oven for a minimum of 18 hours.
[0102] Characterize by FTIR-ATR, contact angle(s) values and EDX.
[0103] The exact formulations with values of xx, yy, zz are shown in Table
1.
Example 10: Preparation of Thicker Coating and Esperox 33 Polymerization
[0104] A mixture containing xx gm of 2-HEMA, yy gm of EOEMA, zz gm of
Esperox 33
(tert-Butyl peroxyneodecanoate and 0.3% by weight (of total mixture weight) of
ethylene glycol
dimethacrylate (EGDMA) was prepared in a clean vial per Table 1. The total
volume of the
mixture was adjusted to about 30 ml. The mixture was placed in a 40 ml glass
vial. A magnetic
stirrer was placed inside the mixture and was heated to 80-90 C for about 8-
10 minutes. The
monomer solution was monitored closely. When the vortex created by the stir-
bar completely
disappeared (e.g. the surface of the liquid was completely flat), the monomer
was removed
quickly from the stir plate and was placed in the ice water. The monomer was
agitated
horizontally until it cooled completely.
[0105] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with the coating
agents. The parts
to be coated were dipped in the above mixture or the viscous solution was
painted over it. The
coated parts were placed at 40 C in an oven for a minimum of 18 hours.
[0106] Characterize by FTIR-ATR, contact angle(s) values and EDX.
[0107] The exact formulations with values of xx, yy, zz are shown in Table
2.
Example 11: Parylene Coating
[0108] The samples of the lens parts to be coated were prepared. The side
to be coated
was exposed and all other areas were protected from contact with coating
agents. The coating
-23-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
was applied at a vendor site. Basically, the solid dimer was heated under
vacuum and vaporized
into a dimeric gas. The gas was then pyrolized to cleave the dimer to its
monomeric form.
[0109] In the room temperature deposition chamber, the monomer gas was
deposited on
all surfaces as a thin, transparent polymer film.
[0110] Characterize by FTIR-ATR, contact angle(s) values and EDX.
Example 12: UV Initiator
[0111] A mixture containing xx gm of 2-HEMA, yy gm of EOEMA, zz gm of 2,2-
azobis
(2,4 dimethyl valeronitrile) and 0.3% by weight (of total mixture weight) of
ethylene glycol
dimethacrylate (EGDMA) were prepared in a clean vial. The mixture was
thoroughly mixed
using a magnetic stirrer making sure that there were no undissolved solid
particles and there
were no schlerian lines visible. The mixture is heated (at 90 C) and stirred
to form oligomers.
The process is terminated when the viscosity is at a selected level (e.g.,
approximately 150-250
cps, approximately 200 cps), and the mixture is then cooled to stop the
reaction. The resulting
mixture is then stored for use.
[0112] The mixture can be dispensed on selected surface(s) for treatment
via a digital
syringe or any of the methods disclosed herein. The treated surfaces are post
treated by allowing
them to sit for 30 minutes at room temperature, and then at 40 C for 18 hours
under argon.
Features Key¨Figures
[0113] Below are the key codes for the features specified in the figures
described herein.
Particular figure features are numbered using the figure number preceding one
of the codes listed
below. For example, the feature number for the AIOL of Figure 1 is 100.
Subsets of a feature
may also receive an alpha designator at the end of the feature number, for
example the bellows
region 140 may be comprised of a first and second bellows region, designated
as 140a and 140b,
respectively.
Feature Description Feature Code Feature Description Feature Code
AIOL 00 outer surface 23
coated surface 01 fluid chamber 30
uncoated surface 02 attenuating layer 31
outer surface 03 first optical components 32
seam/bond joint 04 coating layer 33
seam/bond joint 05 second optical components 34
-24-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
seam/bond joint 06 AIOL structure 35
masked regions 07 base layer 36
cross section 08 bellows region 40
machined surface 09 fixed lens assembly 50
first component 10 optical portion 51
inner surface 11 passages 52
fluid accommodating lens 12 continuous thickened region 53
outer surface 13 fixed lens inner surface 54
second component 20 engagement feature 55
inner surface 21 fluid accommodating lens 60
Examples
[0114] Several
aspects of the present technology are set forth in the following examples.
1. An accommodating intraocular lens system, comprising:
an accommodating structure including a first component, a second component
posterior
of the first optical component, an inner fluid chamber between the first and
second optical components, and an outer fluid chamber fluidically coupled to
the
inner fluid chamber,
wherein the first component and the second component are hydrophilic
structures, and
wherein one or more surfaces of the accommodating structure include a surface
treatment to decrease a roughness of the corresponding treated region.
2. The accommodating intraocular lens system of example 1 wherein the
treated
surfaces comprise the same proportion of hydrophobic and hydrophilic elements
as the base
material.
3. The accommodating intraocular lens system of example 1 wherein the
treated
surfaces comprise a proportion of approximately 25% 2-Hydroxyethyl
methacrylate (HEMA)
elements to approximately 75% hydrophobic elements.
4. The accommodating intraocular lens system of any one of examples 1-3
wherein
an inner surface defining, at least in part, the inner fluid chamber includes
the surface treatment.
-25-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
5. The accommodating intraocular lens system of any one of examples 1-4
wherein
the accommodating structure comprises an outer surface defined, at least in
part, by a periphery
of the first component and the second component, and wherein at least a
portion of the outer
surface includes the surface treatment.
6. The accommodating intraocular lens system of any one of examples 1-5
wherein
the surface treatment comprises a coating applied to the corresponding one or
more surfaces of
the accommodating structure.
7. The accommodating intraocular lens system of example 1 wherein the
surface
treatment is adapted to reduce the density of hydrophilic end groups from the
treated region.
8. The accommodating intraocular lens system of example 1 wherein the
surface
treatment is adapted to mask hydrophilic end groups from the treated region.
9. The accommodating intraocular lens system of any one of examples 1-8
wherein
the outer fluid chamber is around at least a portion of the inner fluid
chamber and configured to
interface with a native eye capsule of a human subject such that fluid flows
between the outer
fluid chamber and the inner fluid chamber to move the first optical element
for providing
accommodation.
10. The accommodating intraocular lens system of any one of examples 1-9,
further
comprising fluid within the inner fluid chamber, wherein the fluid comprises a
hydrophobic
liquid.
11. The accommodating intraocular lens system of any one of examples 1-10
wherein
the first and second components are bonded to one another.
12. The accommodating intraocular lens system of any one of examples 1-11
wherein
the first and second components are bonded to one another at one or more bond
sites, and wherein
the one or more bond sites do not include the surface treatment.
-26-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
13. The accommodating intraocular lens system of any one of examples 1-12
wherein
the first and second components are sufficiently flexible to be folded into a
reduced cross-section
delivery configuration.
14. An accommodating intraocular lens system for implantation within a lens
capsule
of a subject, comprising:
an accommodating structure including a first optical component and a second
optical
component coupled to the first optical component along a boundary surface, an
inner fluid chamber between the first and second optical components, and an
outer fluid chamber fluidically coupled to the inner fluid chamber;
wherein the accommodating structure comprises a substantially hydrophilic
outer surface
and a substantially hydrophobic inner surface as defined by inner fluid
chamber
and the outer fluid chamber,
a coating on at least one of the first optical component and the second
optical component,
wherein the coating changes hydrophobicity of the treated regions as compared
to untreated regions of the first and second optical components.
15. The accommodating intraocular lens system of example 14 wherein the
hydrophilic outer surface of the accommodating structure is composed of a
first material, and
wherein the coating comprises a prepolymer of the first material.
16. The accommodating intraocular lens system of example 15 wherein first
material
comprises a copolymer of 2-Hydroxyethyl methacrylate (HEMA) and 2-Ethoxyethyl
methacrylate (EOEMA)
17. The accommodating intraocular lens system of example 15 wherein the
coating
comprises EOEMA.
18. The accommodating intraocular lens system of any one of examples 14-17
wherein the coating reduces surface roughness of the treated regions as
compared with untreated
regions of the first and second optical components.
-27-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
19. The accommodating intraocular lens system of example 14 wherein the
coating
increases hydrophobicity of the treated regions as compared to untreated
regions.
20. An accommodating intraocular lens for placement within a lens capsule
of a
subject, the accommodating intraocular lens comprising:
a first component having a first optical region and a first bellows region;
a second component having a second optical region and a second bellows region,
the
second component coupled to the first component;
a first fluid chamber between the first optical region and the second optical
region;
a second fluid chamber between the first bellows region and the second bellows
region,
the second fluid chamber in fluid communication with the first fluid chamber
to
transfer fluid between the first fluid chamber and the second fluid chamber in
response to shape changes of the lens capsule to provide optical power changes
to the accommodating intraocular lens; and
a surface treatment applied to a first treated region of the first component
and a second
treated region of the second component, wherein the surface treatment
increases
the hydrophobicity of the corresponding first and second treated regions.
21. An accommodating intraocular lens for placement within a lens capsule
of a
subject, the accommodating intraocular lens comprising a generally hydrophilic
surface, and
wherein the accommodating intraocular lens includes a coating on at least a
portion of the
surface, and further wherein the coated regions of the surface of the
accommodating intraocular
lens are more hydrophobic than untreated regions of the surface.
Conclusion
[0115] The above detailed description of embodiments of the technology are
not intended
to be exhaustive or to limit the technology to the precise form disclosed
above. Although specific
embodiments of, and examples for, the technology are described above for
illustrative purposes,
various equivalent modifications are possible within the scope of the
technology as those skilled
in the relevant art will recognize. For example, any of the features of the
intraocular lens systems
described herein may be combined with any of the features of the other
intraocular lenses
described herein and vice versa. Moreover, although steps are presented in a
given order,
-28-
CA 03064855 2019-11-25
WO 2018/222579
PCT/US2018/034858
alternative embodiments may perform steps in a different order. The various
embodiments
described herein may also be combined to provide further embodiments.
[0116] From the foregoing, it will be appreciated that specific embodiments
of the
technology have been described herein for purposes of illustration, but well-
known structures
and functions have not been shown or described in detail to avoid
unnecessarily obscuring the
description of the embodiments of the technology. Where the context permits,
singular or plural
terms may also include the plural or singular term, respectively.
[0117] Moreover, unless the word "or" is expressly limited to mean only a
single item
exclusive from the other items in reference to a list of two or more items,
then the use of "or" in
such a list is to be interpreted as including (a) any single item in the list,
(b) all of the items in
the list, or (c) any combination of the items in the list. Additionally, the
term "comprising" is
used throughout to mean including at least the recited feature(s) such that
any greater number of
the same feature and/or additional types of other features are not precluded.
It will also be
appreciated that specific embodiments have been described herein for purposes
of illustration,
but that various modifications may be made without deviating from the
technology. Further,
while advantages associated with some embodiments of the technology have been
described in
the context of those embodiments, other embodiments may also exhibit such
advantages, and
not all embodiments need necessarily exhibit such advantages to fall within
the scope of the
technology. Accordingly, the disclosure and associated technology can
encompass other
embodiments not expressly shown or described herein.
-29-
